Treatment Outcomes of Intralesional Steroid Injection for Refractory Vocal Process Granuloma
ABSTRACT Objectives Vocal process granuloma (VPG) is a chronic condition resulting from a mucoperichondrial injury of vocal process. Initial conservative treatment typically involves vocal hygiene education and antireflux medication. Treatment challenges arise with refractory cases. Outcomes of seco...
Saved in:
Published in | Clinical otolaryngology Vol. 49; no. 6; pp. 822 - 826 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.11.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | ABSTRACT
Objectives
Vocal process granuloma (VPG) is a chronic condition resulting from a mucoperichondrial injury of vocal process. Initial conservative treatment typically involves vocal hygiene education and antireflux medication. Treatment challenges arise with refractory cases. Outcomes of second‐line treatments such as surgical excision and botulinum toxin injections remain inconsistent. Thus, we propose this study to investigate the effectiveness of intralesional steroid injections for refractory VPG.
Methods
We conducted a retrospective review of 23 patients with VPG who showed no improvement after 3 months of proton pump inhibitors. These patients underwent one to three courses of monthly in‐office intralesional steroid injections as a second‐line therapy. Treatment outcomes were evaluated by measuring the size of the VPG relative to the length of the vocal folds before and after the final injection procedure.
Results
Results showed a significant reduction in VPG size from baseline of 27.74 ± 15.06 to 5.48 ± 8.95 (p < .001). 15 out of 23 patients were responsive (size reduction ≥ 75%) to intralesional steroid injection. Alcohol consumption and longer symptom duration were associated with a poor response (size reduction <75%), whereas prior intubation was associated with better response.
Conclusions
For refractory VPG not responding to conservative treatment, intralesional steroid injection appears to be a promising alternative option without significant adverse effects. |
---|---|
AbstractList | ABSTRACT
Objectives
Vocal process granuloma (VPG) is a chronic condition resulting from a mucoperichondrial injury of vocal process. Initial conservative treatment typically involves vocal hygiene education and antireflux medication. Treatment challenges arise with refractory cases. Outcomes of second‐line treatments such as surgical excision and botulinum toxin injections remain inconsistent. Thus, we propose this study to investigate the effectiveness of intralesional steroid injections for refractory VPG.
Methods
We conducted a retrospective review of 23 patients with VPG who showed no improvement after 3 months of proton pump inhibitors. These patients underwent one to three courses of monthly in‐office intralesional steroid injections as a second‐line therapy. Treatment outcomes were evaluated by measuring the size of the VPG relative to the length of the vocal folds before and after the final injection procedure.
Results
Results showed a significant reduction in VPG size from baseline of 27.74 ± 15.06 to 5.48 ± 8.95 (p < .001). 15 out of 23 patients were responsive (size reduction ≥ 75%) to intralesional steroid injection. Alcohol consumption and longer symptom duration were associated with a poor response (size reduction <75%), whereas prior intubation was associated with better response.
Conclusions
For refractory VPG not responding to conservative treatment, intralesional steroid injection appears to be a promising alternative option without significant adverse effects. Vocal process granuloma (VPG) is a chronic condition resulting from a mucoperichondrial injury of vocal process. Initial conservative treatment typically involves vocal hygiene education and antireflux medication. Treatment challenges arise with refractory cases. Outcomes of second-line treatments such as surgical excision and botulinum toxin injections remain inconsistent. Thus, we propose this study to investigate the effectiveness of intralesional steroid injections for refractory VPG. We conducted a retrospective review of 23 patients with VPG who showed no improvement after 3 months of proton pump inhibitors. These patients underwent one to three courses of monthly in-office intralesional steroid injections as a second-line therapy. Treatment outcomes were evaluated by measuring the size of the VPG relative to the length of the vocal folds before and after the final injection procedure. Results showed a significant reduction in VPG size from baseline of 27.74 ± 15.06 to 5.48 ± 8.95 (p < .001). 15 out of 23 patients were responsive (size reduction ≥ 75%) to intralesional steroid injection. Alcohol consumption and longer symptom duration were associated with a poor response (size reduction <75%), whereas prior intubation was associated with better response. For refractory VPG not responding to conservative treatment, intralesional steroid injection appears to be a promising alternative option without significant adverse effects. ObjectivesVocal process granuloma (VPG) is a chronic condition resulting from a mucoperichondrial injury of vocal process. Initial conservative treatment typically involves vocal hygiene education and antireflux medication. Treatment challenges arise with refractory cases. Outcomes of second‐line treatments such as surgical excision and botulinum toxin injections remain inconsistent. Thus, we propose this study to investigate the effectiveness of intralesional steroid injections for refractory VPG.MethodsWe conducted a retrospective review of 23 patients with VPG who showed no improvement after 3 months of proton pump inhibitors. These patients underwent one to three courses of monthly in‐office intralesional steroid injections as a second‐line therapy. Treatment outcomes were evaluated by measuring the size of the VPG relative to the length of the vocal folds before and after the final injection procedure.ResultsResults showed a significant reduction in VPG size from baseline of 27.74 ± 15.06 to 5.48 ± 8.95 (p < .001). 15 out of 23 patients were responsive (size reduction ≥ 75%) to intralesional steroid injection. Alcohol consumption and longer symptom duration were associated with a poor response (size reduction <75%), whereas prior intubation was associated with better response.ConclusionsFor refractory VPG not responding to conservative treatment, intralesional steroid injection appears to be a promising alternative option without significant adverse effects. Vocal process granuloma (VPG) is a chronic condition resulting from a mucoperichondrial injury of vocal process. Initial conservative treatment typically involves vocal hygiene education and antireflux medication. Treatment challenges arise with refractory cases. Outcomes of second-line treatments such as surgical excision and botulinum toxin injections remain inconsistent. Thus, we propose this study to investigate the effectiveness of intralesional steroid injections for refractory VPG.OBJECTIVESVocal process granuloma (VPG) is a chronic condition resulting from a mucoperichondrial injury of vocal process. Initial conservative treatment typically involves vocal hygiene education and antireflux medication. Treatment challenges arise with refractory cases. Outcomes of second-line treatments such as surgical excision and botulinum toxin injections remain inconsistent. Thus, we propose this study to investigate the effectiveness of intralesional steroid injections for refractory VPG.We conducted a retrospective review of 23 patients with VPG who showed no improvement after 3 months of proton pump inhibitors. These patients underwent one to three courses of monthly in-office intralesional steroid injections as a second-line therapy. Treatment outcomes were evaluated by measuring the size of the VPG relative to the length of the vocal folds before and after the final injection procedure.METHODSWe conducted a retrospective review of 23 patients with VPG who showed no improvement after 3 months of proton pump inhibitors. These patients underwent one to three courses of monthly in-office intralesional steroid injections as a second-line therapy. Treatment outcomes were evaluated by measuring the size of the VPG relative to the length of the vocal folds before and after the final injection procedure.Results showed a significant reduction in VPG size from baseline of 27.74 ± 15.06 to 5.48 ± 8.95 (p < .001). 15 out of 23 patients were responsive (size reduction ≥ 75%) to intralesional steroid injection. Alcohol consumption and longer symptom duration were associated with a poor response (size reduction <75%), whereas prior intubation was associated with better response.RESULTSResults showed a significant reduction in VPG size from baseline of 27.74 ± 15.06 to 5.48 ± 8.95 (p < .001). 15 out of 23 patients were responsive (size reduction ≥ 75%) to intralesional steroid injection. Alcohol consumption and longer symptom duration were associated with a poor response (size reduction <75%), whereas prior intubation was associated with better response.For refractory VPG not responding to conservative treatment, intralesional steroid injection appears to be a promising alternative option without significant adverse effects.CONCLUSIONSFor refractory VPG not responding to conservative treatment, intralesional steroid injection appears to be a promising alternative option without significant adverse effects. |
Author | Yu, Po‐Jun Hung, Wei‐Chen Wang, Chi‐Te |
Author_xml | – sequence: 1 givenname: Po‐Jun surname: Yu fullname: Yu, Po‐Jun organization: Far Eastern Memorial Hospital – sequence: 2 givenname: Wei‐Chen surname: Hung fullname: Hung, Wei‐Chen organization: Far Eastern Memorial Hospital – sequence: 3 givenname: Chi‐Te orcidid: 0000-0002-9999-1291 surname: Wang fullname: Wang, Chi‐Te email: drwangct@gmail.com organization: University of Taipei |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39135379$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kc1KAzEUhYNU7I8ufAEZcKOLtskkncwsS9FaKFS0uhJCmrmBKTOTmmSQvr2pbV0UzSbh8p1D7jld1KpNDQhdEzwg4QyVkQPCYoLPUIdwlvUZS5PW75unbdR1bo0xo5iTC9SmGaEjyrMO-lhakL6C2keLxitTgYuMjma1t7IEV5haltGrB2uKPEzXoHyYRdrY6AW0lcobu43ejQrYszUKnIumVtZNaSp5ic61LB1cHe4eent8WE6e-vPFdDYZz_sq_AL3IeOJGsUEKFsxRqjCKc7SZKRVnuBYcqAxxbnKIV3pVGOuwqo85ynRNE8lX9Eeutv7bqz5bMB5URVOQVnKGkzjBMVZTJMRTUhAb0_QtWlsWDJQhMQJ4zyJA3VzoJpVBbnY2KKSdiuOuQVguAeUNc5Z0EIVXu6iCbkVpSBY7JoRoRnx00xQ3J8ojqZ_sQf3r6KE7f-gmCzGe8U324WbxQ |
CitedBy_id | crossref_primary_10_1111_coa_14229 |
Cites_doi | 10.1016/j.jvoice.2015.07.015 10.1016/j.amjoto.2017.01.039 10.1017/S0022215107000710 10.1002/hed.21091 10.1177/000348941011900509 10.1111/coa.12021 10.4103/sja.SJA_543_18 10.1007/978-981-16-3303-4_17 10.1177/0003489414525921 10.1093/alcalc/agy063 |
ContentType | Journal Article |
Copyright | 2024 John Wiley & Sons Ltd. |
Copyright_xml | – notice: 2024 John Wiley & Sons Ltd. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 8FD FR3 K9. M7Z P64 7X8 |
DOI | 10.1111/coa.14210 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Biochemistry Abstracts 1 Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Biochemistry Abstracts 1 ProQuest Health & Medical Complete (Alumni) Engineering Research Database Technology Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE Biochemistry Abstracts 1 MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1749-4486 |
EndPage | 826 |
ExternalDocumentID | 39135379 10_1111_coa_14210 COA14210 |
Genre | perspective Journal Article |
GrantInformation_xml | – fundername: Far Eastern Memorial Hospital funderid: FEMH‐2023‐C‐025 – fundername: Far Eastern Memorial Hospital grantid: FEMH-2023-C-025 |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1OC 29B 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5RE 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EAS EBC EBD EBS EBX EJD EMB EMK EMOBN EPT ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 Q~Q R.K RJQFR ROL RX1 SUPJJ SV3 TEORI TUS UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR XG1 ZGI ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM 8FD AAMMB AEFGJ AGXDD AIDQK AIDYY FR3 K9. M7Z P64 7X8 |
ID | FETCH-LOGICAL-c3530-e976c521e34b4413c0809865fcd602a7e3230dcde8bf8f07c4217d781f3d8a7b3 |
IEDL.DBID | DR2 |
ISSN | 1749-4478 1749-4486 |
IngestDate | Fri Jul 11 12:25:37 EDT 2025 Sat Jul 26 01:02:19 EDT 2025 Thu Apr 03 07:04:24 EDT 2025 Tue Jul 01 02:40:32 EDT 2025 Thu Apr 24 23:09:15 EDT 2025 Wed Jan 22 17:16:13 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | voice contact ulcer minimally invasive surgery proton pump inhibitor contact granuloma laryngopharyngeal reflux |
Language | English |
License | 2024 John Wiley & Sons Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3530-e976c521e34b4413c0809865fcd602a7e3230dcde8bf8f07c4217d781f3d8a7b3 |
Notes | This study was supported by funds from Far Eastern Memorial Hospital (FEMH‐2023‐C‐025). Po‐Jun Yu and Wei‐Chen Hung are equal contributors to this work and designated as co‐first authors. Correction added on 2 October 2024, after first online publication: The abstract section has been removed in this version. Funding ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-9999-1291 |
PMID | 39135379 |
PQID | 3112647762 |
PQPubID | 36531 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_3092365361 proquest_journals_3112647762 pubmed_primary_39135379 crossref_citationtrail_10_1111_coa_14210 crossref_primary_10_1111_coa_14210 wiley_primary_10_1111_coa_14210_COA14210 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | November 2024 2024-11-00 2024-Nov 20241101 |
PublicationDateYYYYMMDD | 2024-11-01 |
PublicationDate_xml | – month: 11 year: 2024 text: November 2024 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford |
PublicationTitle | Clinical otolaryngology |
PublicationTitleAlternate | Clin Otolaryngol |
PublicationYear | 2024 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2016; 30 2013; 38 2009; 31 2010; 119 2008; 122 2021 2017; 38 2019; 54 2019; 13 2014; 123 e_1_2_9_11_1 e_1_2_9_10_1 e_1_2_9_9_1 e_1_2_9_8_1 e_1_2_9_7_1 e_1_2_9_6_1 e_1_2_9_5_1 e_1_2_9_4_1 e_1_2_9_3_1 e_1_2_9_2_1 |
References_xml | – volume: 123 start-page: 314 year: 2014 end-page: 320 article-title: Vocal Process Granulomas: A Systematic Review of Treatment publication-title: Annals of Otology, Rhinology and Laryngology – volume: 30 start-page: 741 year: 2016 end-page: 743 article-title: Botulinum Toxin A for Treatment of Contact Granuloma publication-title: Journal of Voice – volume: 122 start-page: 824 year: 2008 end-page: 828 article-title: Botulinum Toxin as Adjunctive Therapy in Refractory Laryngeal Granuloma publication-title: Journal of Laryngology and Otology – volume: 54 start-page: 62 year: 2019 end-page: 69 article-title: Alcohol Consumption and the Risk of Gastroesophageal Reflux Disease: A Systematic Review and Meta‐Analysis publication-title: Alcohol and Alcoholism – volume: 31 start-page: 1309 year: 2009 end-page: 1315 article-title: Endoscopic Nasopharyngectomy With Potassium‐Titanyl‐Phosphate (KTP) Laser for Early Locally Recurrent Nasopharyngeal Carcinoma publication-title: Head & Neck – volume: 119 start-page: 325 year: 2010 end-page: 330 article-title: Inhaled Triamcinolone With Proton Pump Inhibitor for Treatment of Vocal Process Granulomas: A Series of 67 Granulomas publication-title: Annals of Otology, Rhinology and Laryngology – volume: 38 start-page: 77 year: 2013 end-page: 81 article-title: Intralesional Steroid Injection: An Alternative Treatment Option for Vocal Process Granuloma in Ten Patients publication-title: Clinical Otolaryngology – volume: 13 year: 2019 article-title: The STROBE Guidelines publication-title: Saudi Journal of Anaesthesia – volume: 38 start-page: 593 year: 2017 end-page: 597 article-title: Comparison of the Effects of Esomeprazole Plus Mosapride Citrate and Botulinum Toxin A on Vocal Process Granuloma publication-title: American Journal of Otolaryngology – year: 2021 – ident: e_1_2_9_8_1 doi: 10.1016/j.jvoice.2015.07.015 – ident: e_1_2_9_9_1 doi: 10.1016/j.amjoto.2017.01.039 – ident: e_1_2_9_7_1 doi: 10.1017/S0022215107000710 – ident: e_1_2_9_10_1 doi: 10.1002/hed.21091 – ident: e_1_2_9_3_1 doi: 10.1177/000348941011900509 – ident: e_1_2_9_5_1 doi: 10.1111/coa.12021 – ident: e_1_2_9_6_1 doi: 10.4103/sja.SJA_543_18 – ident: e_1_2_9_4_1 doi: 10.1007/978-981-16-3303-4_17 – ident: e_1_2_9_2_1 doi: 10.1177/0003489414525921 – ident: e_1_2_9_11_1 doi: 10.1093/alcalc/agy063 |
SSID | ssj0043071 |
Score | 2.3894012 |
Snippet | ABSTRACT
Objectives
Vocal process granuloma (VPG) is a chronic condition resulting from a mucoperichondrial injury of vocal process. Initial conservative... Vocal process granuloma (VPG) is a chronic condition resulting from a mucoperichondrial injury of vocal process. Initial conservative treatment typically... ObjectivesVocal process granuloma (VPG) is a chronic condition resulting from a mucoperichondrial injury of vocal process. Initial conservative treatment... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 822 |
SubjectTerms | Adult Aged Botulinum toxin Clinical outcomes contact granuloma contact ulcer Female Glucocorticoids - administration & dosage Granuloma Granuloma, Laryngeal - drug therapy Granulomas Humans Hygiene Injection Injections, Intralesional Laryngeal Diseases - drug therapy laryngopharyngeal reflux Male Middle Aged minimally invasive surgery proton pump inhibitor Proton pump inhibitors Retrospective Studies Size reduction Steroids Treatment Outcome Vocal Cords - injuries voice |
Title | Treatment Outcomes of Intralesional Steroid Injection for Refractory Vocal Process Granuloma |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcoa.14210 https://www.ncbi.nlm.nih.gov/pubmed/39135379 https://www.proquest.com/docview/3112647762 https://www.proquest.com/docview/3092365361 |
Volume | 49 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4hDohLC7TQhQW5VQ-9BG3iJHbEabViC0gLEgXEASnyU-KVoN3NAX49Y-chaKmEuEXJJH7MTOYbe2YM8JOyRAthw8BKlQUxt1EgqQ4DhV5cxDVaROnWISfH6cF5fHSZXC7AXpsLU9eH6BbcnGb4_7VTcCFnL5RclQLVPPLpVS5WywGi0650VIyyG9bJkNiFmPGmqpCL4unefG2L_gGYr_GqNzjjz3DVdrWOM7ndreZyVz39VcXxg2NZgU8NECXDWnJWYcEUa7A0abbav8DVWRuCTk6qOX7QzEhpyaFfDDZ1LQ_yB7lSXmu8e-NDugqCGJicGjv1x_g8kgtnKkmTjUB-o2Gs7sp78RXOx_tno4OgOYohUDShg8AgalFo6Q2NJQIo6uqTZzxNrNLpIBLMUHRltNKGS8vtgCkcDNOMh5ZqLpik67BYlIX5BgQRD3eoTCdcxSZSGaM6CZlCKISupVA9-NUyJVdNnXJ3XMZd3vorOFu5n60e_OhIH-riHG8R9VvO5o1-znLqMqdihpagB9-7x6hZbrtEFKaskGaA4DdNaBr2YKOWiK4VmrnzQliGnfV8_X_z-ehk6C8230-6BcsRYqc65bEPi_NpZbYR-8zljhfyZy28_cU |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LT9wwEB5RKrVcaGkLLIXiVq3US9AmTmLnwAHx6C6wIMFScUAKiR8SrwSxGyH4TfwV_hNj5yFoQeLCgVuUWHFsz3i-cWa-AfhJWSCTRLuOTkXk-Fx7Tkql6wj04jwu0SKm5hyytxV29vz1_WB_BG7qXJiSH6I5cDOaYfdro-DmQPqelos8QT1Hl6UKqdxQV5fosA0Wuyu4ur88b221v9xxqpoCjqABbTsKza9Ak6WonyISoIZoO-JhoIUM217CFEVMLoVUPNVct5nADphk3NVU8oSlFN_7Bt6aCuKGqX9lpyGr8lFb3DL9EgftM17xGJm4oeZTH1q__yDtQ4RsTdzaB7itJ6eMbDlZKIbpgrj-hzfytczeRxivsDZZKpVjAkZU9gne9apogs9w0K-j7Ml2McQRqAHJNena825V0pWQXRS8_Eji3WMbtZYRhPlkR-kLW6noivw1aIBUCRfkD9r-4jQ_S77A3ouMbRJGszxT00AQ1HEDPGXAha88ETEqA5cJRHvoPSeiBb9rKYhFRcVuKoKcxrVLhqsT29VpwY-m6XnJP_JYo9lalOJqCxrE1CSH-QyNXQu-N49x8zB_hJJM5QW2aSO-DwMaui2YKkWw6YVGpiQKi_BjrSA93X28vL1kL2ae33Qe3nf6vc14s7u18RXGPISKZYbnLIwOLwo1h1BvmH6zGkbg8KWF8g5a_1qB |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1JT90wEB5RkFAvbG3hsdWtWqmXoCROYufAAfF48KBARaHigBQSLxJbgngvQvCX-Cv8KMbOotJF6oVDb1FixbE94_nGmfkG4BNloUxT7Tk6E7ETcO07GZWeI9CL87lEi5iZc8jdvWjrKNg-Do9H4KHJhan4IdoDN6MZdr82Cn4t9U9KLooU1Rw9ljqickfd3aK_Nljtd3FxP_t-b-NwfcupSwo4gobUdRRaX4EWS9EgQyBADc92zKNQCxm5fsoURUguhVQ801y7TGAHTDLuaSp5yjKK730FY0HkxqZORPeg5aoKUFm8KvsSxxwwXtMYmbCh9lOfG7_fEO1zgGwtXG8SHpu5qQJbLlbKYbYi7n-hjfxPJm8KJmqkTdYq1ZiGEZXPwPhuHUvwBk4Omxh7sl8OcQBqQApN-va0W1VkJeQ7il1xJvHuuY1ZywmCfHKg9I2tU3RHfhgsQOp0C7KJlr-8LK7St3D0ImN7B6N5kas5IAjpuIGdMuQiUL6IGZWhxwRiPfSdU9GBL40QJKImYjf1QC6TxiHD1Uns6nTgY9v0umIf-VOjxUaSknoDGiTUpIYFDE1dBz60j3HrMP-D0lwVJbZxEd1HIY28DsxWEtj2QmNTEIXF-LFWjv7efbK-v2Yv5v-96XsY_9btJV_7ezsL8NpHnFildy7C6PCmVEuI84bZstUvAqcvLZNP0NdZMA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Treatment+Outcomes+of+Intralesional+Steroid+Injection+for+Refractory+Vocal+Process+Granuloma&rft.jtitle=Clinical+otolaryngology&rft.au=Yu%2C+Po%E2%80%90Jun&rft.au=Hung%2C+Wei%E2%80%90Chen&rft.au=Wang%2C+Chi%E2%80%90Te&rft.date=2024-11-01&rft.issn=1749-4478&rft.eissn=1749-4486&rft.volume=49&rft.issue=6&rft.spage=822&rft.epage=826&rft_id=info:doi/10.1111%2Fcoa.14210&rft.externalDBID=10.1111%252Fcoa.14210&rft.externalDocID=COA14210 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1749-4478&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1749-4478&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1749-4478&client=summon |